Tilray stock gets a lift after B.C. cannabis company reveals new deal with Sandoz

Tilray stock gets a lift after B.C. cannabis company reveals new deal with Sandoz

TORONTO — Tilray Inc. shares jumped Tuesday after the B.C.-based company took another step to strengthen its medical marijuana business outside Canada through a new collaboration with Novartis pharmaceutical group’s Sandoz AG.

“Tilray is a global company and we’re thrilled to build upon the success and momentum from our existing agreement with Sandoz Canada by taking our partnership global,” Tilray chief executive Brendan Kennedy said Tuesday.

Under its original agreement, announced in January 2018 after several months of talks, the companies began shipping non-combustible medical products with the Tilray and Sandoz/Novartis brands to customers in Canada last June.

The new global arrangement allows Tilray to use the Sandoz supply chain, sales force and global distribution network to distribute Tilray medical cannabis products, Kennedy said.

The number of countries that have legalized medical cannabis has more than doubled to 35 from 15 in 2010, when Kennedy got into the business.

“It’s very clear to me how we go from 35, to 40, to 50, 60 countries globally … and this agreement enables us to ensure that our products get into the hands of more patients around the world,” Kennedy said.

Tilray Inc. shares were up 17 per cent or US$11.33 at US$77.22 as of 1:30 p.m. on the Nasdaq market, but remained well below their 2018 high of US$300 set on Sept. 19.

Kennedy thinks Germany — with a larger population and economy than Canada — is a major opportunity because any doctor in that country is allowed to write a prescription to any patient for any illness with insurance coverage for medical cannabis products.

The United States is more difficult — because its federal law is more restrictive — but Kennedy said there are also encouraging trends in that country, including the electoral defeat of a staunch House of Representatives opponent of medical marijuana in November and the removal of Jeff Sessions as the U.S. attorney general.

In addition, there are now 33 states that have legalized cannabis for medical purposes, 10 that have legalized it for recreational use by adults, and favourable revisions to the U.S. Farm Bill that have been passed by both houses of the U.S. Congress.

“We are hopeful that President Trump will sign it this week. That will provide an excellent opportunity for Tilray to capitalize on … hemp-derived CBD (cannabidiol) in the U.S.”

CBD has significant medical benefits with little to no psychoactive effects — unlike THC, which is scientifically known as delta-9-tetrahydrocannabinol and generally known as the ingredient in pot that gives users a high.

Kennedy said the U.S. Drug Enforcement Administration and the U.S. Federal Drug Administration have also given approvals for Tilray to export medical cannabis from Canada for a clinical trial in the United States, where Sandoz has a major pharmaceutical sales operation.

The Sandoz announcement follows recent additions to Tilray’s international advisory board, which includes former finance ministers from Canada, Australia and Germany and politically connected representatives from the United States — former Vermont governor Howard Dean and former lieutenant governor of Maryland Michael Steele.

Interest in publicly traded cannabis companies has been stoked by Canada’s legalization of recreational use of marijuana and its plan to make consumable forms of the drug legal next year.

In addition, there have been a number of partnerships and tie-ups between cannabis companies and more established producers of consumer goods including beer makers Molson Coors and Constellation Brands, and cigarette maker Altria Group Inc.

Under the new agreement Tuesday, Sandoz may support Tilray’s commercialization of non-smokable and non-combustible medical cannabis products and work together on developing new products.

They may also partner to educate pharmacists and physicians about medical cannabis products.

Tilray Canada is a subsidiary of Tilray Inc., which is which is listed on the Nasdaq stock market and has operations in Australia, New Zealand, Germany, Latin America, Portugal and Canada.

In Canada, Tilray’s operation in Nanaimo, B.C., is licenced to produce dried cannabis and cannabis extracts, including both bottled oil and capsules, for medical purposes in Canada.

The company also has a licenced facility in Enniskillen, Ont., that it intends to use to service the adult market for dried cannabis and it’s seeking a licence for a processing facility in London, Ont.

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Alberta had 1,571 active COVID-19 cases on Tuesday. THE CANADIAN PRESS
Alberta’s central zone now has 1,101 active COVID-19 cases

Provincial death toll has risen by nine

Dustin Mitchell (Coats) is wanted by police in relation to a homicide this past Wednesday. (Photo contributed by Red Deer RCMP)
Red Deer RCMP looking for man in relation to homicide

An arrest warrant has been issued for a Red Deer man in… Continue reading

COVID-19. (Image courtesy CDC)
Alberta reports 1,731 new COVID-19 cases on Saturday

The province’s central zone has 992 active cases

Collin Orthner, manager at McBain Camera in downtown Red Deer, stands behind the store’s counter on Saturday. (Photo by Sean McIntosh/Advocate staff)
A few Red Deer businesses happy with Black Friday results

While this year’s Black Friday wasn’t as successful as it was in… Continue reading

Le Chateau Inc. is the latest Canadian firm to start producing personal protective equipment for health care workers, in a July 3, 2020 story. (Photo by THE CANADIAN PRESS)
Hundreds of millions of dollars for frontline workers yet to be released, says Alberta Federation of Labour

Information recently released by the Alberta Federation of Labour suggests more than… Continue reading

Idyllic winter scenes are part of the atmosphere of the holiday season, and are depicted in many seasonal movies. How much do you know about holiday movies? Put your knowledge to the test. (Pixabay.com)
QUIZ: Test your knowledge of holiday movies and television specials

The festive season is a time for relaxing and enjoying some seasonal favourites

Conservative MP Pierre Poilievre speaks during a news conference Monday, Nov. 16, 2020 in Ottawa. Poilievre says building up the Canadian economy post-pandemic can't be achieved without a massive overhaul of the tax system and regulatory regime. THE CANADIAN PRESS/Adrian Wyld
Conservatives attack Trudeau’s ‘reset’ but they have ideas for their own

‘We don’t need subsidized corporate welfare schemes that rely on endless bailouts from the taxpayer’

In this undated photo issued by the University of Oxford, a volunteer is administered the coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. Pharmaceutical company AstraZeneca said Monday Nov. 23, 2020, that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. (University of Oxford/John Cairns via AP)
Moderna chairman says Canada near head of line for 20 million vaccine doses

Trudeau created a firestorm when he said Canadians will have to wait a bit to get vaccinated

There were 47 new COVID-19 cases in Alberta Tuesday. (THE CANADIAN PRESS/Paul Chiasson)
Spread of COVID-19 in Brampton, Ont., linked to systemic factors, experts say

‘We’re tired. We’re numb. We’re overworked. We’re frustrated, because it’s not our rules’

The courthouse in Iqaluit is shown on Wednesday, Oct. 7, 2020. Three Nunavut judges, including the chief justice, are at odds over whether prison conditions caused by the COVID-19 pandemic should be considered when sentencing offenders in the territory. THE CANADIAN PRESS/Emma Tranter
Nunavut judges disagree on how to sentence offenders during pandemic

IQALUIT — Three Nunavut judges, including the territory’s chief justice, are at… Continue reading

A corrections officer opens the door to a cell in the segregation unit at the federal Fraser Valley Institution for Women during a media tour, in Abbotsford, B.C., Thursday, Oct. 26, 2017. Independent reviews of the hundreds of inmates placed in segregation over the past year found only a handful were inappropriate, new government data indicate. THE CANADIAN PRESS/Darryl Dyck
Few federal inmates moved from solitary after external reviews, new data show

‘There can be rare cases where the removal may not be immediate’

A couple embrace during a ceremony to mark the end of a makeshift memorial for victims of the Toronto van attack, at Yonge St. and Finch Ave. in Toronto on Sunday, June 3, 2018. THE CANADIAN PRESS/Cole Burston
‘I’ve been spared a lot,’ van attack survivor says as she watches trial alone

Court has set up a private room for victims and families of those killed in the Toronto van attack

Banff National Park. (The Canadian Press)
Study finds train speed a top factor in wildlife deaths in Banff, Yoho national parks

EDMONTON — A study looking at 646 wildlife deaths on railway tracks… Continue reading

Cows on pasture at the University of Vermont dairy farm eat hay Thursday, July 23, 2020, in Burlington, Vt. Canadian dairy farmers are demanding compensation from the government because of losses to their industry they say have been caused by a series of international trade deals. THE CANADIAN PRESS/AP-Lisa Rathke
Feds unveil more funding for dairy, poultry and egg farmers hurt by free trade deals

OTTAWA — Canadian egg and poultry farmers who’ve lost domestic market share… Continue reading

Most Read